Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series C round grosses $65mm for aesthetics company Sientra

Executive Summary

New investor Abingworth Management led a $65mm Series C financing for Sientra Inc. (implantable devices for cosmetic and reconstructive surgery). Returning shareholders also joined, including Clarus Ventures and OrbiMed Advisors. The money will support marketing activities for the company’s Silimed portfolio of silicone gel breast implants, approved by the FDA in early March.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies